National Health (Weighted average disclosed price – April 2026 reduction day) Determination 2025
7Adjusted approved ex-manufacturer price for brands of pharmaceutical items
Start here
Get a plain-English read of 7
Turn the raw legal text into a practical explanation grounded in National Health (Weighted average disclosed price – April 2026 reduction day) Determination 2025.
7 Adjusted approved ex-manufacturer price for brands of pharmaceutical items
The adjusted approved ex-manufacturer price of a brand of pharmaceutical item specified in column 2 of the table to Schedule 1 is the amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 6 of this instrument.
Note: Subsection 99ADB(7) of the Act provides that a determination made under subsection 99ADB(4) in relation to a brand of pharmaceutical item may include the adjusted approved ex-manufacturer price of the brand of pharmaceutical item.